跳至主要内容
临床试验/CTRI/2025/05/086633
CTRI/2025/05/086633尚未招募Unknown

A Clinical Study to Evaluate the Anti-Pigmentation activity of Vitamin-C Moisturizer

Pureplay Skin Science Pvt Ltd1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年5月17日

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
36
试验地点
1
主要终点
2. Change in Wrinkle count

研究概览

简要总结

A single blind one arm study.

Each participant entering the trial will be assigned to a regimen ofinvestigational product.

Day 0 (T0) - Baseline Measurements:

  1. Skin Gloss (Glossymeter): (0, 14, 28 days)

  2. Skin Hydration (Corneometer): (T0, 30min, 14, 28 days)

  3. TEWL (Tewameter): (0, 14, 28 days)

  4. Skin Pigmentation (Melanin Index) (Mexameter): (0, 14, 28 days)

  5. Dark Spots (Visioface): (0, 14, 28 days)

  6. Skin Color (Chromameter): (0, 14, 28 days)

  7. HD Imaging with DSLR: (0, 28 days)

  8. Visioscan Imaging: (0, 28 days)

Dedicated Questionnaire (CRF)

  1. Light weight

  2. Quick Absorbing

  3. Non-Irritant

  4. Non-Sticky

  5. Non-Greasy

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)

入选标准

  • Gender: Non-pregnant, non-lactating female aged between18 to
  • Subject with Pigmentation.
  • Subject willing to give written informed consent
  • Women of child bearing potential must have a negative urine pregnancy test
  • Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE.
  • Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

排除标准

  • Subjects who are pregnant, breast feeding, or planning to become pregnant during the study
  • Volunteers with skin conditions such as eczema, psoriasis,etc
  • Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition.
  • Have open sore or open lesions in the treatment area
  • Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product.
  • Have participated in any interventional clinical trial in the previous 30 days.
  • Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents.
  • Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), including corticosteroids.
  • Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years.

结局指标

主要结局

2. Change in Wrinkle count

时间窗: At T0, T14 and T28Days

4. Change in Melanin Index

时间窗: At T0, T14 and T28Days

1. Change in Dark spots & Pigmentation

时间窗: At T0, T14 and T28Days

3. Change in skin gloss

时间窗: At T0, T14 and T28Days

5. Change in skin lightness

时间窗: At T0, T14 and T28Days

6. Change in skin Hydration and TEWL

时间窗: At T0, T14 and T28Days

次要结局

  • Not Applicable(Not Applicable)

研究者

发起方
Pureplay Skin Science Pvt Ltd
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验